Search Results

New Frontiers in Alcoholism and Addiction Treatment

Authors: Nava, Felice; Vendramin, Andrea; Manzato, Ezio; Cibin, Mauro; Lucchini, Alfio

Source: Recent Patents on CNS Drug Discovery, Volume 5, Number 1, January 2010 , pp. 81-94(14)

Publisher: Bentham Science Publishers

Other Drugs Acting on Nervous System Associated with QT-Interval Prolongation

Authors: Keller, Guillermo A.; Ponte, Marcelo L.; Di Girolamo, Guillermo

Source: Current Drug Safety, Volume 5, Number 1, January 2010 , pp. 105-111(7)

Publisher: Bentham Science Publishers

Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: lipid emulsion, nanostructured lipid carriers and solid lipid nanoparticles

Authors: Wang, Jhi-Joung; Liu, Kuo-Sheng; Sung, K. C.; Tsai, Chia-Yin; Fang, Jia-You

Source: Journal of Microencapsulation, Volume 26, Number 8, December 2009 , pp. 734-747(14)

Publisher: Informa Healthcare

Why do patients report transferring between methadone and buprenorphine?

Source: Drug and Alcohol Review, Volume 28, Number 6, November 2009 , pp. 686-687(2)

Publisher: Blackwell Publishing

Take multiple factors into account when choosing the best opioid for pain therapy in paediatric palliative care

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 25, Number 11, November 2009 , pp. 9-14(6)

Publisher: Adis International

Buprenorphine withdrawal: Irritability and other symptoms in a child: case report

Source: Reactions, Volume 1, Number 1274, 2009-10-17 , pp. 14-14(1)

Publisher: Adis International

Determination of Naloxone and Nornaloxone (Noroxymorphone) by High-Performance Liquid Chromatography-Electrospray Ionization- Tandem Mass Spectrometry

Authors: Fang, Wenfang B.; Chang, Yan; McCance-Katz, Elinore F.; Moody, David E.

Source: Journal of Analytical Toxicology, Volume 33, Number 8, October 2009 , pp. 409-417(9)

Publisher: Preston Publications

Subcutaneous pre-anaesthetic medication with acepromazine-buprenorphine is effective as and less painful than the intramuscular route

Authors: Gurney, M.; Cripps, P.; Mosing, M.

Source: The Journal of Small Animal Practice, Volume 50, Number 9, September 2009 , pp. 474-477(4)

Publisher: Blackwell Publishing

Buprenorphine/dipotassium clorazepate/naltrexone: Interaction between buprenorphine and naltrexone leading to opioid withdrawal symptoms, and dipotassium clorazepate-induced anterograde amnesia: case report

Source: Reactions, Volume 1, Number 1272, 2009-10-03 , pp. 10-11(2)

Publisher: Adis International

Equipotent doses to switch from high doses of opioids to transdermal buprenorphine

Authors: Mercadante, Sebastiano; Casuccio, Alessandra; Tirelli, Walter; Giarratano, Antonello

Source: Supportive Care in Cancer, Volume 17, Number 6, June 2009 , pp. 715-718(4)

Publisher: Springer

Uses of Diverted Methadone and Buprenorphine by Opioid-Addicted Individuals in Baltimore, Maryland

Authors: Mitchell, Shannon Gwin; Kelly, Sharon; Brown, Barry; Reisinger, Heather Schacht; Peterson, James; Ruhf, Adrienne; Agar, Michael; O'Grady, Kevin; Schwartz, Robert

Source: American Journal on Addictions, Volume 18, Number 5, September 2009 , pp. 346-355(10)

Publisher: Informa Healthcare

Spotlight on Buprenorphine/Naloxone in the Treatment of Opioid Dependence†

Authors: Orman, Jennifer S.; Keating, Gillian M.

Source: CNS Drugs, Volume 23, Number 10, 1 October 2009 , pp. 899-902(4)

Publisher: Adis International

Antinociceptive effects of epidural buprenorphine or medetomidine, or the combination, in conscious cats

Authors: STEAGALL, P. V. M.; MILLETTE, V.; MANTOVANI, F. B.; GILBERT, P.; LUNA, S. P. L.; DUKE-NOVAKOVSKI, T.

Source: Journal of Veterinary Pharmacology & Therapeutics, Volume 32, Number 5, October 2009 , pp. 477-484(8)

Publisher: Blackwell Publishing

Plasma buprenorphine concentrations after the application of a 70 μg/h transdermal patch in dogs. Preliminary report

Authors: ANDALUZ, A.; MOLL, X.; VENTURA, R.; ABELLÁN, R.; FRESNO, L.; GARCÍA, F.

Source: Journal of Veterinary Pharmacology & Therapeutics, Volume 32, Number 5, October 2009 , pp. 503-505(3)

Publisher: Blackwell Publishing

The In Vivo Response of Novel Buprenorphine Metabolites, M1 and M3, to Antiretroviral Inducers and Inhibitors of Buprenorphine Metabolism

Authors: Moody, David E.; Chang, Yan; Huang, Wei; McCance-Katz, Elinore F.

Source: Basic & Clinical Pharmacology & Toxicology, Volume 105, Number 3, September 2009 , pp. 211-215(5)

Publisher: Blackwell Publishing

Effect of plasma proteins on buprenorphine transfer across dually perfused placental lobule

Authors: Nanovskaya, Tatiana; Bowen, Robin; Patrikeeva, Svetlana; Hankins, Gary; Ahmed, Mahmoud

Source: Journal of Maternal-Fetal and Neonatal Medicine, Volume 22, Number 8, August 2009 , pp. 646-653(8)

Publisher: Informa Healthcare

μ-Opioid receptor-stimulated synthesis of reactive oxygen species is mediated via phospholipase D2

Authors: Koch, Thomas; Seifert, Anja; Wu, Dai-Fei; Rankovic, Marija; Kraus, Jürgen; Börner, Christine; Brandenburg, Lars-Ove; Schröder, Helmut; Höllt, Volker

Source: Journal of Neurochemistry, Volume 110, Number 4, August 2009 , pp. 1288-1296(9)

Publisher: Blackwell Publishing

EXPANDED ACCESS TO SEPs AND OTHER HARM REDUCTION MEASURES IN FRANCE

Source: Addiction, Volume 104, Number 9, September 2009 , pp. 1447-1448(2)

Publisher: Blackwell Publishing

Medication Assisted Treatment in the Treatment of Drug Abuse and Dependence in HIV/AIDS Infected Drug Users

Authors: Kresina, Thomas F.; Bruce, R. D.; McCance-Katz, Elinore F.

Source: Current HIV Research, Volume 7, Number 4, July 2009 , pp. 354-364(11)

Publisher: Bentham Science Publishers

Buprenorphine abuse: Endocarditis complicated by protein-losing enteropathy: case report

Source: Reactions, Volume 1, Number 1259, 2009-07-04 , pp. 11-11(1)

Publisher: Adis International